Back
iShares iBoxx $ Inv Grade Corporate Bond ETF Vs. Viking Therapeutics Industry Stock Comparison
Sell
32
LQD
iShares iBoxx $ Inv Grade Corporate Bond ETF
Last Price:
106.78
Seasonality Move:
-1.18%
Sell
28
VKTX
Viking Therapeutics
Last Price:
40.94
Seasonality Move:
40.87%
Sell
32
iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD)
is a Sell
Is iShares iBoxx $ Inv Grade Corporate Bond ETF a Buy, Sell or Hold?
- The current iShares iBoxx $ Inv Grade Corporate Bond ETF [LQD] share price is $107.14. The Score for LQD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- LQD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LQD Stock Price Chart
What is iShares iBoxx $ Inv Grade Corporate Bond ETF's stock price today?
-
The iShares iBoxx $ Inv Grade Corporate Bond ETF share price today is $107.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LQD is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $38.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
LQD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 30.58 | Sell |
Chaikin Money Flow: | -31528535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (108.31 - 110.25) | Sell |
Bollinger Bands (100): | (109.02 - 112.26) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.91 | Sell |
Relative Strength Index (14 RSI): | 23.24 | Sell |
Chaikin Money Flow: | -10764092 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.91 - 53.55) | Sell |
Bollinger Bands (100): | (52.21 - 67.17) | Sell |
LQD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 109.19 | Sell |
20-day SMA: | 109.51 | Sell |
50-day SMA: | 109.53 | Sell |
200-day SMA: | 108.98 | Sell |
8-day EMA: | 108.87 | Sell |
20-day EMA: | 109.31 | Sell |
50-day EMA: | 109.7 | Sell |
200-day EMA: | 109.24 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.82 | Sell |
20-day SMA: | 49.84 | Sell |
50-day SMA: | 58.67 | Sell |
200-day SMA: | 62.24 | Sell |
8-day EMA: | 46.02 | Sell |
20-day EMA: | 49.86 | Sell |
50-day EMA: | 55.23 | Sell |
200-day EMA: | 54.61 | Sell |
iShares iBoxx $ Inv Grade Corporate Bond ETF Earnings Growth & LQD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
iShares iBoxx $ Inv Grade Corporate Bond ETF Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |